NRC HEALTH (NRC)
Health Care · healthcare technology / SaaS · NASDAQ
NRC Health offers an AI-powered healthcare experience management platform designed to help organizations improve patient and employee engagement through deep human insights.
What NRC HEALTH does
NRC Health provides a healthcare experience management platform that helps healthcare organizations improve patient, clinician, and employee experiences. The company offers AI-enabled products to collect, analyze, and deliver feedback, focusing on creating meaningful human connections within healthcare delivery. Its services aim to transform the patient experience through research, insights, and action-oriented enablement solutions.
Themes: healthcare experience management, patient engagement, AI in healthcare, healthcare analytics, human-centered design
Fundamentals
- Price$22.19 as of 2026-08-21 close
- Market cap$491M as of 2026-08-21
- 1-year return+52.9% 2025-08-21 close $14.51 → 2026-08-21 close $22.19
- P/E80.45 as of 2026-08-24
- Net margin+4.2% as of 2026-08-24
- Gross margin+61.8% as of 2026-08-24
- ROE+48.5% as of 2026-08-24
- Debt / equity13.75 as of 2026-08-24
- Revenue growth (YoY)-0.2% as of 2026-08-24
- Revenue CAGR (3y)-3.2% SEC XBRL
- Beta0.29 as of 2026-08-24
- Last reported earnings2026-07-28 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.2%; 2-year non-decreasing per-share dividend streak (SEC XBRL).
How NRC compares in its sector
- price-to-earnings ratiotop 25% 203 covered Health Care peers, as of 2026-08-24
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating margintop 25% 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitytop 10% 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRbottom 25% 402 covered Health Care peers
- indicated dividend yieldmiddle range 71 covered Health Care peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, NRC's dividend was covered by reported results (free-cash-flow payout 70%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings not reported
- Free-cash-flow payout70% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How NRC HEALTH looks technically
NRC HEALTH (NRC) is trading 22.4% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 80 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 9 trading days ago (its momentum flipped positive). It made a new 20-day low about 18 trading days ago. Trading volume is running unusually high — about 3.2× its 30-day average, a sign of heightened interest.
Trend
7
| Distance from the 200-day | it is trading 22.4% above its 200-day average, the long-term trend line — a longer-term uptrend | +22.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $20.80 | $20.80 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $18.13 | $18.13 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 23 calendar days ago — the swings before that are what the structure reading is measured on | 23 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 80 trading days ago — a "golden cross", a bullish long-term signal | 80 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 16, below the 25 that marks a real trend) | 15.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 60.2 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($19.12 to $22.99) — its "stochastic" reading is 79 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 79.3 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 9 trading days ago (its momentum flipped positive) | 9 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $23.68 | $23.68 |
|---|---|---|
| From the 52-week high | it is 6.3% below its 52-week high (its highest price of the past year) | -6.3% |
| Above the 52-week low | it is 101.5% above its 52-week low (its lowest price of the past year) | +101.5% |
| Below the 52-week high | it is 6.3% below its highest point of the past year | 6.3% |
| Since a 20-day breakout | it made a new 20-day low about 18 trading days ago | 18 sessions |
| Since a 55-day breakout | it made a new 55-day high about 34 trading days ago | 34 sessions |
| All-time high | its highest closing price on record is $71.35 (set on 2020-01-24) | $71.35 |
| Given back of the 52-week move | over the past year its closes ranged ($11.42 to $22.77), and it has given back only a small part of its rise from last year’s low — 5% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $15.39 to $15.76. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 5.1% |
| From the all-time high | it is 68.9% below its all-time high | -68.9% |
| Nearest price level | it is trading 2.8% above a support level at $21.57 — a price it turned at twice since 2024-09-23, most recently on 2024-11-11. Since 2024-08-21 it has 13 such levels below the current price and 1 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -2.8% |
| All-time low | its lowest closing price on record is $9.76 (set on 2025-04-21) | $9.76 |
| Above the all-time low | it is 127.5% above its all-time low | +127.5% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 66th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.11 between its high and its low — about 5.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.11 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $18.32 and $23.07 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $18.32 – $20.70 – $23.07 |
| Typical daily range (% of price) | its price moves about 5.0% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 5.0% |
| Stretch from the 200-day average | it is trading 3.7 daily ranges above its 200-day average price (22.4% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 3.7 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 3.2× its 30-day average, a sign of heightened interest | 3.17× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a bullish engulfing | 4 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 4 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.3% |
|---|---|---|
| Gap filled | a 10.4% gap up opened on 2026-06-11 has been "filled" 49 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 49 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 1.0 percentage points (the stock gained 3.3% while the market gained 2.3%) | +1.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 13.4 percentage points (the stock gained 16.5% while the market gained 3.1%) | +13.4% |
| vs market, 6 months | over the past 6 months this stock beat the market by 51.3 percentage points (the stock gained 62.3% while the market gained 11.1%) | +51.3% |
| vs market, 12 months | over the past 12 months this stock beat the market by 32.4 percentage points (the stock gained 52.9% while the market gained 20.5%) | +32.5% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 0 of the 9 technical signals we can compute for it are currently in a bearish state — these describe past price behaviour, not a forecast | 0 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 5.0% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 10.3% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +5.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 21% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $18.36 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +20.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 7% above the average price paid since it last reported on 2026-07-28 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $20.66 — a volume-weighted average of daily closes over 19 sessions, not a true tick-by-tick VWAP. | +7.4% |
Price levels it has turned at before
NRC last closed at $22.19 on 2026-08-21. Since 2024-08-21 it has turned at 13 prices below its last close and 1 above; the 3 nearest below and the nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $21.57 | Support | 2.8% below the last close | turned there twice · 2024-09-23 to 2024-11-11 |
| $22.84 | Resistance | 2.9% above the last close | turned there six times · 2024-09-03 to 2026-07-16 |
| $21.17 | Support | 4.6% below the last close | turned there three times · 2024-09-10 to 2026-07-10 |
| $20.02 | Support | 9.8% below the last close | turned there three times · 2024-10-21 to 2024-12-05 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Unusually heavy trading volume · trendless / choppy (low ADX) · beating the market · Trading above the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$26.00 range $26.00 – $26.00
Analyst estimates, as of 2026-08-23. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for NRC
- Consensus EPS estimate$0.21 next reporting period, as of 2026-08-23
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High competition and potential for industry consolidation leading to price pressure.","Risk of non-renewal of customer service contracts or loss of key customers.","Dependence on IT infrastructure and risk of cyber-attacks or platform failures."]
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
Most recent open-market transaction: 2026-02-17. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about NRC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding NRC as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 1,619,846
- Reported value $27,553,998
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 1 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
NRC had 515,170 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
NRC had 2.33% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.37 days to cover at the same settlement.
- Reported short interest (shares) 515,170
- Short interest (% of shares outstanding) 2.33%
- Prior settlement (shares) 520,821
- Reported change -1.09%
- Days to cover (reported) 5.37
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Press Ganey
- Qualtrics (XM)
- Medallia
- HealthStream (HSTM)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare NRC vs…
Frequently asked questions
What does NRC HEALTH (NRC) do?
NRC Health provides a healthcare experience management platform that helps healthcare organizations improve patient, clinician, and employee experiences. The company offers AI-enabled products to collect, analyze, and deliver feedback, focusing on creating meaningful human connections within healthcare delivery. Its services aim to transform the patient experience through research, insights, and action-oriented enablement solutions.
What sector is NRC HEALTH (NRC) in?
NRC HEALTH (NRC) is classified in the Health Care sector. Its industry is healthcare technology / SaaS. It trades on NASDAQ.
Does NRC pay a dividend?
Yes — NRC HEALTH (NRC) pays a dividend, with an indicated yield of about 1.16% and 2-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are NRC HEALTH's (NRC) competitors?
Notable peers of NRC HEALTH (NRC) include Press Ganey, Qualtrics, Medallia and HealthStream. This peer set is informational only — not financial advice.
Is NRC HEALTH (NRC) overbought or oversold right now?
NRC HEALTH (NRC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on NRC come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.